What is the best course of action for an asymptomatic patient with bradycardia (heart rate of 37 beats per minute)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Asymptomatic Bradycardia with Heart Rate of 37 bpm

Asymptomatic sinus bradycardia, even with a heart rate as low as 37 bpm, requires no treatment and no in-hospital monitoring. 1

Key Clinical Principle

The absence of symptoms is the critical determining factor—there is no minimum heart rate threshold that mandates intervention. 2 Untreated sinus node dysfunction does not influence survival, and asymptomatic sinus bradycardia is explicitly not an indication for pacing. 1

Recommended Management Approach

Immediate Assessment

  • Document the rhythm with a 12-lead ECG to confirm sinus bradycardia (normal P-wave morphology preceding each QRS complex). 1, 2
  • Verify the patient is truly asymptomatic—specifically assess for absence of syncope, presyncope, fatigue, dyspnea on exertion, chest pain, altered mental status, hypotension, or heart failure symptoms. 1, 3, 2
  • No monitoring is required for asymptomatic sinus bradycardia in either inpatient or outpatient settings. 1

Evaluate for Reversible Causes

Even though treatment is not indicated, identifying underlying etiologies is reasonable:

  • Review medications: beta blockers, calcium channel blockers, digoxin, antiarrhythmic drugs, ivabradine. 1, 3
  • Check thyroid function tests to exclude hypothyroidism. 1, 3
  • Assess electrolytes (particularly potassium and magnesium). 1, 3
  • Screen for obstructive sleep apnea if bradycardia occurs during sleep or patient has risk factors. 1, 4
  • Consider athletic conditioning—resting heart rates in the 30s are physiologic in well-conditioned athletes due to dominant parasympathetic tone. 2, 5

When to Consider Further Evaluation

Ambulatory monitoring is only indicated if the patient later develops symptoms that need correlation with bradycardia. 1, 2 The choice of monitoring duration depends on symptom frequency:

  • 24-72 hour Holter monitor for daily symptoms. 2
  • 30-day event monitor for weekly symptoms. 2
  • Implantable loop recorder for very infrequent symptoms. 2, 4

Common Pitfalls to Avoid

  • Do not treat based solely on heart rate number—a heart rate of 37 bpm in an asymptomatic patient is benign and requires no intervention. 1, 2
  • Do not initiate atropine or other chronotropic agents in the absence of symptoms or hemodynamic compromise. 1, 3
  • Do not refer for pacemaker evaluation without documented symptomatic bradycardia. 1
  • Do not order unnecessary monitoring—asymptomatic bradycardia does not require telemetry or continuous ECG monitoring. 1

Special Considerations

If the patient is on negative chronotropic medications (beta blockers, calcium channel blockers) that are medically necessary (e.g., for post-MI, heart failure, or atrial fibrillation rate control), these should generally be continued as long as the patient remains asymptomatic. 1 The bradycardia itself does not necessitate medication adjustment.

Chronotropic incompetence (inadequate heart rate response to exercise) may be present even with normal resting heart rate, but this requires symptoms during exertion to warrant evaluation with exercise stress testing. 1, 2

Prognosis

Asymptomatic sinus bradycardia has a benign prognosis and does not affect survival. 1 The natural history does not warrant prophylactic intervention. Athletes and young healthy individuals commonly have resting heart rates in the 30s-40s during sleep and at rest without adverse outcomes. 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bradycardia Symptoms and Intervention Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Management of Symptomatic Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Significant Bradycardia Detected During Home Sleep Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.